G52D (p.Gly52Asp) variant of CTLA4 (Cytotoxic T-lymphocyte protein 4)

G52D (p.Gly52Asp) in CTLA4 (Cytotoxic T-lymphocyte protein 4) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency; not pro. The available variant effect predictions contribute to a CATVariant prioritization score of 0.41 / 1. The record also includes structural context.

G52D (p.Gly52Asp) variant details